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Abstract
Background We examined a bedside technique transce-
rebral double-indicator dilution (TCID) for global cerebral
blood flow (CBF) as well as the concept of effective
cerebral perfusion pressure (CPPeff) during different treat-
ment options for intracranial hypertension, and compared
global CBF and CPPeff with simultaneously obtained
conventional parameters.
Methods Twenty-six patients developing intracranial hyper-
tension in the course of traumatic brain injury or subarachnoid
hemorrhage were prospectively analyzed using a combined
assessment during elevated ventilation (n = 15) or osmo-
therapy (hypertonic saline or mannitol). For calculation of
global CBF, injections of ice-cold indocyanine green boluses
were performed and temperature and dye concentration
changes were monitored in the thoracic aorta and the jugular
bulb. CBF was then calculated according to the mean transit
time principle. Estimation of CCP, the arterial pressure at
which cerebral blood flow becomes zero, was performed by
synchronized registration of corresponding values of blood
flow velocity in the middle cerebral artery and arterial pres-
sure and extrapolation to zero-flow velocity. CPPeff was
calculated as mean arterial pressure minus critical closing
pressure (CPPeff = MAPc - CCP).
Results Elevated ventilation causes a decrease in both
ICP (P < 0.001) and CBF (P < 0.001). While CPPconv
increased (P < 0.001), CPPeff decreased during this obser-
vation (P = 0.002). Administration of osmotherapeutic
agents resulted in a decrease of ICP (P < 0.001) and a
temporary increase of CBF (P = 0.052). CPPconv and CPPeff
showed no striking difference under osmotherapy.
Conclusion TCID allows repeated measurements of glo-
bal CBF at the bedside. Elevated ventilation lowered and
osmotherapy temporarily raised global CBF. In situations
of increased vasotonus, CPPeff is a better indicator of blood
flow changes than conventional CPP.
Keywords Transcerebral double-indicator dilution
technique  Global cerebral blood flow  Effective cerebral
perfusion pressure  Critical closing pressure  Intracranial
hypertension  Mannitol  Hypertonic saline
Introduction
Insufficient cerebral blood flow (CBF) is associated with
poor outcome in patients suffering from intracranial
hypertension higher than 20 mmHg. Therefore, it is a
general practice in neurointensive care units to monitor and
assure a correct cerebral perfusion pressure (CPP) to ensure
sufficient blood flow in these patients [1]. Conventionally,
CPP is calculated as cerebral mean arterial blood pressure
(MAPc) minus intracranial pressure (ICP) (CPPconv =
MAPc - ICP). Therapeutic interventions such as elevated
ventilation or administration of osmotic agents in patients
with intracranial hypertension are recommended to reduce
ICP and in turn increase CPP [1]. However, this equation
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does not include all factors that affect CPP, e.g., vasomotor
tone and venous pressure [2]. From a physiological point of
view, the effective CPP is the difference between momen-
tary arterial pressure and the pressure at which cerebral
blood flow in the precapillary bed suspends [3]. Determining
this particular pressure, called critical closing pressure
(CCP) (CPPeff = MAPc - CCP) [3–5] and obtainable with
help of transcranial Doppler, can be used to monitor CPP.
In addition to mere observation of perfusion pressure
(CPP) there is a strong interest in direct measurement of
perfusion itself (CBF). Invasive probes, however, can only
indicate regional blood flow conditions, and patient transfer
from the neurointensive care unit to radiological units to
assess global CBF provides only momentary values and
presents a high risk for critically unstable patients. In order
to overcome these disadvantages a new method has been
introduced for the bedside monitoring of global CBF in
intensive care patients that refers to the mean transit time
principle [6], the transcerebral double-indicator dilution
technique (TCID) which has shown a good correlation of
CBF values in comparison to the Kety–Schmidt method, as
well as good reliability [7–10].
In this study, we assessed global CBF by means of the
TCID technique and calculated CPPeff and CPPconv in
patients with intracranial hypertension in the course of two
medical therapy options, elevated mechanical ventilation
or osmotherapy. Our aim is to test the two methods for
determination of global CBF and CPPeff in clinical practice
and to find out whether CPPeff could be superior to CPPconv
in indicating cerebral blood flow changes.
Methods
Patient Characteristics and Intensive Care Management
This prospective clinical study was approved by the Univer-
sity of Bonn Institutional Review Board and written consent
was obtained from all the patients or their closest relatives.
All the patients underwent simultaneous bedside assess-
ment of global CBF, ICP, CPPconv, CCP, and CPPeff together
with basic hemodynamic parameters such as heart rate (HR),
continuous cerebral arterial pressure (APc), mean cerebral
arterial pressure (MAPc), and arterial and cerebrovenous
blood gas samples. All the patients were kept under sedation,
analgesia, and mechanical ventilation according to the local
intensive care unit regimen for patients with intracranial
hypertension.
Patient Groups
Patients admitted to the University of Bonn Medical Center
are addressed either to the Anaesthesiology or to the
Neurosurgery intensive care unit, depending on the severity
of the brain lesions.
Group 1 (Elevated Ventilation)
Group 1 included 15 consecutive patients treated in the
intensive care unit of the Department of Anaesthesiology,
for initially mild traumatic brain injuries (MTBI). Trau-
matic CT findings were present in all these patients. The
injuries were judged mild due to clinical impact and
radiologic extension and were graded according to the
initial Marshall CT Sore [11, 12]. The patients developed
intracranial hypertension during their hospitalization in the
course of systemic inflammatory response syndromes
(SIRS) [13, 14] and were treated by an elevation of
mechanical ventilation in reference to their baseline set-
tings to lower arterial carbon dioxide tension (PaCO2) by
7 mmHg. Measurements were performed under baseline
ventilation conditions (T0) and after undergoing elevated
ventilation for approximately 30 min (TElevVent) (Fig. 1).
Group 2 (Osmotherapy)
Group 2 included a consecutive group of 11 patients with
intracranial hypertension due to aneurysmal subarachnoid
hemorrhage (SAH) or severe traumatic brain injury (TBI),
hospitalized in the Department of Neurosurgery. As for
Group 1, the Marshall CT Score was applied for TBI
patients and the WFNS Scale for SAH patients [11, 12, 15].
Patients in Group 2 were treated by intravenous adminis-
tration of the hypertonic saline HyperHES 7.2% (n = 8)
or, if baseline sodium serum levels were too high, by
mannitol 20% (n = 3). As in group 1, the baseline mea-
surement T0 was performed immediately prior to therapy.
Then, the respective infusions of 150 mg/kg b.w. as for
HyperHES and 0.5 g/kg b.w. as for mannitol (=usual
amount for a single adult application), were administered
within 15 min. Measurements were repeated 15 (T15) and
60 min (T60) after administration (Fig. 1).
Measurement of Global CBF via TCID Technique
CBF was measured with the TCID technique [10]. The
underlying theory to this method is the mean transit time
principle according to which blood flow through the brain
can be calculated when the transcerebral mean transit time
of a diffusible indicator from the organ’s arterial inlet to its
venous outlet as well as the partition coefficient k between
brain and blood for the respective indicator are known
(CBF = k/mtt [ml/s/g]) [16]. The transcerebral mean
transit time in turn consists of an intravascular and an
extravascular part (mtt = mttiv + mttev) [17, 18]. The
TCID technique makes use of two simultaneously
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administered indicators: negative heat (ice-cold isotonic
saline bolus injections), serving as a highly diffusible
indicator, and dye concentration (indocyanine green in the
bolus liquid) serving as a strictly intravascular indicator. If
after indicator injection their concentration changes over
time at the arterial inlet and venous outlet of the brain are
continuously recorded, then the mean transit time can be
calculated using computer-assisted via a transport function
[16]. Negative heat is sufficient for calculation of CBF, but
indocyanine green in addition allows to verify the intra-
vascular part of the transport function [17–19]. The
partition coefficient for the highly diffusible heat can be
assumed to be 1 ml/g [20] (CBF = 1/mtt [ml/g/s]) and the
formula can be modified to the standard unit for CBF
(CBF = 60 9 100/mtt [ml/100 g/min]) [10].
Technically, the method requires simultaneous regis-
tration of thermo- and dye-dilution curves via two
intravascular fiberoptic thermistor catheters at the arterial
inflow and venous outflow of the brain as well as a central
venous line for the indicator injection (Fig. 2). One cath-
eter (PV-2024, 4 French, Pulsion Medical Devices,
Munich, Germany) was placed in the thoracic aorta via
retrograde puncture of the left femoral artery. The second
catheter was placed in the jugular bulb via retrograde
puncture of the internal jugular vein. Correct positioning of
the catheter tips was verified by fluoroscopy. Rapid bolus
injections of ice-cold indocyanine green (standard amount
25 mg in 40 ml NaCl, T < 5C) into the central venous
line were performed and the resulting inlet and outlet
dilution curves for the two indicators were digitally
recorded (COLD Z-021, Pulsion, Munich, Germany,
Fig. 2). CBF was then calculated offline with a portable
computer by curve analysis software written in Pascal [10].
Arterial and Intracranial Pressure Measurements
Cerebral arterial pressure was continuously monitored and
digitally recorded at a sample rate of 50 Hz (for assessment
of CPP, see below) by the same intravascular catheter
located in the thoracic aorta, with a casual pressure trans-
ducer calibrated to the level of the Foramen of Monro.
Mean arterial pressure (MAPc) was calculated from these
recordings. ICP was monitored by means of conventional
intraventricular probes (Duisburger Nadel; Pilling Weck,
Karlstein, Germany).
Critical Closing Pressure and CPPeff
Estimation of critical closing pressure (CCP) is based on
the fact that the regression of cerebral AP of each single
heart beat and corresponding flow velocity is linear and,
when extrapolated, shows a positive pressure intercept at
zero-flow velocity [2]. At this arterial pressure, in the small
cerebral resistance vessels the effective downstream pres-
sure becomes zero and vessel flow suspends, consequently
causing zero-flow velocity at the arterial observation site,
in our study the middle cerebral artery. Continuous moni-
toring of flow velocity in the middle cerebral artery (VMCA)
was performed at a depth of 45–55 mm with a 2-MHz
transcranial Doppler probe (Multidop T; DWL, Sipplingen,
Germany) fixed to the patient’s head using a device-
adapted holder apparatus. All Doppler probe adjustments
Fig. 1 Study protocol for patients undergoing elevated ventilation
(Group 1) or osmotherapy (Group 2). Time points of measures:
T0 = prior to elevated ventilation or prior to osmotherapy, respec-
tively; TElevVent = under elevated ventilation of approximately
30 min; T15 = 15 min after onset of osmotherapy (hypertonic saline
or mannitol); T60 = 60 min after onset of osmotherapy. Measure-
ments contained global CBF, ICP, APc, MAPc, VMCA, arterious, and
cerebrovenous blood gas samples. CCP, CPPeff, and CPPconv were
calculated from these parameters
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were performed by the same investigator (M. Ja¨gersberg).
No patient suffered angiographic vasospasm at the moment
of assessment. APc was monitored in the aorta as men-
tioned above. Both curves of APc and VMCA were
simultaneously recorded at a sample rate of 50 Hz (Fig. 3).
Offline, the time lag between the two curves was com-
pensated by iterative regression analysis to find
corresponding pressure-flow values and CCP was esti-
mated in a heartbeat-to-heartbeat analysis from zero-flow
velocity as extrapolated by digital regression analysis of
APc–VMCA plots (Fig. 3). During 30 s, CCPs of each
heartbeat were estimated and then averaged to gain an
actual CCP independent of respiration artifacts. Hence
CPPeff was calculated as MAPc minus CCP [2].
Statistics
Data in figures and text are expressed as mean ± standard
deviation (SD), in absolute numbers and relative percent-
age changes to corresponding baseline levels (T0 = 100%)
Fig. 2 Transcerebral double-indicator dilution technique. Left: ice-
cold indocyanine green dye bolus injections into the right atrium were
performed. Two combined fiberoptic thermistor catheters placed in
the thoracic aorta and the jugular bulb registered resulting thermo-
and dye-dilution curves at the respective sites. Right: typical thermo-
(DT) and dye-dilution (CICG) changes over time measured at arterial
inlet (aorta) and venous outlet (jugular bulb) of the brain. Differences
in delay and damping of the jugular curves between the two indicators
are due to the kinetic character of the respective indicator. With help
of these arterial inlet and venous outlet curves immediate calculation
of global CBF was possible (based on [10])
Fig. 3 Estimation of the critical closing pressure for determination of
effective cerebral perfusion pressure. Left: graph of simultaneously
recorded parameters of APc calibrated to the level of the head and
VMCA in the middle cerebral artery drawn over time at a sample rate
of 50 Hz. Corresponding values of pressure and flow velocity were
found shifting the curves to maximal correlation using iterative
regression analysis. Right: values of VMCA drawn over corresponding
values of APc for a single heartbeat. Determination of CCP by a
regression line extrapolated to zero-flow velocity. CCPs for each
single heartbeat were obtained over 30 s and afterward averaged to
rule out respiration artifacts (based on [2])
228 Neurocrit Care (2010) 12:225–233
for each treatment. Correlation and significance using the
Pearson’s correlation coefficient (r) and Student’s t test,
respectively, was calculated with help of Microsoft Excel
2003 SP3.
Results
In total, 63 measurements for CBF, CPPconv and CPPeff
were obtained in 26 patients during hyperventilation
[Group 1, n = 15, aged 54 ± 17 years, 10 men, 5 women;
MTBI with initial Marshall CT Scores 2 (94), 3 (97) and 6
(94)] and during osmotherapy [Group 2, n = 11, aged
53 ± 18 years, 6 men, 5 women; SAH n = 6, WFNS
Grades 4 and 5, TBI n = 5, Marshall CT Score 3(91),
4(92) and 5(92)]. Relevant results are shown in Fig. 4. No
complications were observed in relation to catheterization,
indicator injection, or the therapy applied.
Technical Aspects of the TCID Technique
Preparation of the indicator injections took about 5 min and
had to be performed 30 min prior to measurement to ensure
ice-cold temperature. Retrograde puncture of the internal
jugular vein was only performed by trained intensivists.
Due to procedure-inherent problems (mainly insufficient
indicator injection speed or catheter tip contact with the
vessel walls) 28.6% of all measurements had to be repe-
ated. Average injection volume and dye dose per patient
was 102.9 ml and 64.3 mg for patients undergoing elevated
ventilation, 154.3 ml and 96.4 mg for patients treated with
osmotherapy.
Elevated Ventilation
The PaCO2 drop in group 1 during elevated ventilation
(PaCO2 at T0 43.7 ± 3.3 mmHg; PaCO2 at TElevVent
36.4 ± 4.2 mmHg, P < 0.001) was associated with a
significant decrease in ICP (P < 0.001) and in CBF
(P < 0.001) in comparison to baseline ventilation levels.
Systemic parameters as HR and MAP remained unchan-
ged. The resulting increase in CPPconv contrasts the
decrease of CPPeff obtained in the same patients. Correla-
tion between CPPconv and CBF was -0.29, between CPPeff
and CBF 0.35 without reaching significance (Fig. 4).
Osmotherapy
Results of hypertonic saline and mannitol are presented
separately due to their different time effects concerning
onset and duration.
In the eight patients treated with hypertonic saline a
significant decrease in ICP (P < 0.0001) during the first
15 min (T0–T15) was observed. The further decrease during
the next 45 min remained significant (P < 0.001) com-
pared to baseline ICP (T0-T60). CBF increased significantly
after 15 min (P = 0.024). However, this effect was no
longer present after 60 min with flow values of CBF
comparable to baseline level. Both, CPPconv and CPPeff had
similar trends without statistical significance (r[CPPconv -
CBF] = 0.3; r[CPPeff - CBF] = 0.59) (Fig. 4).
As for the three patients treated with mannitol, a strong
decrease in ICP was accompanied by an important, obser-
vation period lasting (T0–T60) increase in CBF. CPPconv
and CPPeff had similar trends to the corresponding CBF
(r[CPPconv - CBF] = -0.42; r[CPPeff - CBF] = -0.03)
(Fig. 4). Due to the small number of patients in this sub-
group none of the observations reached significance.
Discussion
In this clinical study, we investigated global CBF at the
bedside with the TCID technique in patients with intra-
cranial hypertension in the course of ICP reduction by
either elevated ventilation or osmotherapy and evaluated
the correlation of global CBF with simultaneously obtained
values of CPPconv and CPPeff. Global CBF significantly
decreased under elevated ventilation and increased under
osmotherapy. During elevated ventilation, CPPeff was
superior when compared with conventially obtained CPP in
reflecting global CBF changes, while after osmotherapy
there was no advantage in assessing CPPeff when compared
with CPPconv. A possible explanation is the strong vasot-
onus following hypocapnia that is not present to this extent
during osmotherapy.
Intracranial Hypertension
The pathologies included in the study, all possibly leading
to intracranial hypertension, were MTBI, TBI and SAH. As
for SAH and TBI, pathophysiologic pathways have been
well examined and we refer to the literature for details [21–
26]. Patients with initially MTBI with minor structural CT
findings may suffer from delayed intracranial hypertension
in the course of a SIRS [13]. The pathogenesis of delayed
intracranial hypertension as a ‘‘second hit’’ in these patients
is not completely understood. The systemic inflammatory
response primarily affects organs other than the blood–
brain-barrier-protected central nervous system. However,
initial mild brain injury weakening this barrier may expose
the brain tissue to the inflammatory process and thus vas-
ogenic and cellular edema [13, 14].
The initial ictus of the diseases mentioned above is
different. However, in clinical practice, patients suffering
from intracranial hypertension are all treated similarly
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Fig. 4 Results of monitored
parameters for patients
undergoing elevated ventilation
(Group 1) or osmotherapy
(Group 2, results for hypertonic
saline and mannitol presented
separately) in mean ± standard
deviation (SD) for absolute
numbers and percentage
changes to baseline levels
(T0 = 100%). Histogram
showing parameter changes in
percent. P values calculated
with Student’s t test. HR heart
rate, MAPc mean arterial
pressure calibrated with
Foramen of Monro, CI cardiac
index, CBF global cerebral
blood flow, ICP intracranial
pressure, CPPconv/CPPeff
conventional/effective cerebral
perfusion pressure, Sjv jugular
venous oxygen saturation, NS
not statistically significant
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concerning neurointensive care management. Thus, we
considered MTBI, TBI, and SAH suitable for evaluation of
the two monitoring tools in our study.
TCID Technique
As compared to intracranial CBF probes, which measure
blood flow in a small region of interest (regional CBF),
TCID provides bedside information about global CBF. As
a jugular bulb catheter is needed, this method cannot be
called non-invasive. However, complications as hematoma,
thrombosis, or infection are rare [27]. Indocyanine green
has proved to be a safe indicator that does not cause
allergic reactions and is not oncogenic [28]. TCID does not
allow for continuous monitoring of blood flow, but can be
repeated several times per day. The risk of affection of
cerebral metabolism by the ice-cold injections is low since
jugular bulb temperature changes are usually less than
0.15C [8]. Measurement failures (28.6% in our series)
have been reported previously (34%) [7], they are easy to
detect and hence do not endanger the accuracy of the
method. However, as each measurement takes time and a
physician, the method demands considerable manpower.
Reliability of Estimation of CCP and CPPeff
An essential step to estimate the critical closing pressure
(CCP) is the linear extrapolation of a regression line of
corresponding values of AP and VMCA to zero-flow
velocity. Legitimation for this extraploration was given by
Early et al. [29] who reduced AP to zero flow in the
monkey and Aaslid et al. [30] who observed pressure-flow
velocity correlation to zero-flow velocity in human beings
undergoing a short cardiac arrest for cardioversion. Cere-
bral autoregulation does not interfere with the calculation,
as single-heartbeat-derived pressure changes are too fast
for the vascular response [31]. An advantage of CPPeff is
that it does not, unlike CPPconv, necessitate placement of an
intracranial pressure probe.
Effects of Elevated Ventilation
PaCO2 induced reduction of cerebral blood volume and
hence ICP does not lead to an increase of CBF due to the
flow-limiting vasoconstructive response. Our findings are
in line with other authors, who observed worsening of CBF
under moderate hyperventilation [32–34].
Taking into consideration the elevated vasomotor tone
in the small resistance vessels, the resulting perfusion
pressure CPPeff is physiologically better adapted to real
flow conditions. The conventional formula CPPconv = -
MAPc - ICP does not respect local vessel reactions.
According to our findings CPPconv cannot be recommended
to monitor blood flow conditions in patients undergoing
elevated ventilation.
Osmotherapy—Effects, Duration, Complications
Both mannitol and hypertonic saline are standard osmo-
therapeutic drugs for intracranial hypertension today. The
osmolalities of mannitol 20% and hypertonic saline 7.2%
(Hyperhes 7.2%) are different, with hypertonic saline 7.2%
being more than twice as strong (2570 mosm/l) as mannitol
20% (1100 mosm/l). However, equal osmolality is not a
methodological demand as the two drugs reduce ICP by
partly different pharmacodynamic ways [35, 36]. Hypertonic
saline is known to reduce ICP in some cases of mannitol-
resistant intracranial hypertension [37, 38], whereas man-
nitol can be applied in patients in whom high sodium serum
levels prohibit hypertonic saline administration.
With regard to statistical significance, our findings
underline the effectiveness of hypertonic saline concerning
reduction of ICP and temporary increase of CBF as well as
the safety of both the drugs (zero adverse effects observed).
Furthermore, our findings indicate that mannitol may have
stronger and longer lasting effects on CBF than hypertonic
saline.
Limitations of the Study
Regional CBF techniques as intraparenchymal probes give
information about regions of interest, e.g., the penumbra.
Global CBF cannot provide this information. Conversely,
regional CBF values are unrepresentative for perfusion of
the brain as a whole. A simultaneous observation of CPP—
a global parameter—and CBF requires a global CBF
technique. TCID presents currently the most handy and
repeatable technique of bedside assessment for global CBF.
Other methods as Kety–Schmidt or xenon computed
tomography, are difficult to apply and limited concerning
repeatability. The simultaneous assessment of blood flow
and perfusion pressure is important, even if direct corre-
lation between CPP and CBF is methodically incorrect: in
clinical practice monitoring at the bedside today is mainly
controlled by CPPconv—to maintain sufficient cerebral
blood flow. However, ‘‘real CPP should not be considered a
number, but rather a condition for cerebral blood to flow
[39]’’. Therefore, simultaneous assessment of global CBF
and of both CPPconv and CPPeff is important to define how
accurately these surrogate parameters indicate blood flow.
TCID is lacking acuity in very low perfusion rates due to
its sensitivity to artifact temperature drifts [9, 10]. In nor-
mal or elevated cerebral perfusion the method has proven
precision. Additionally, important intensive care parame-
ters such as cardiac output, intrathoracic blood volume, and
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lung water simultaneously become available by applying
this technique.
CPPeff is extrapolated from blood flow velocities in the
middle cerebral artery (MCA). In situations of different
vasotonus between the two hemispheres the result might
not be representative for the contralateral artery. Care has
to be taken for the choice of the measured side, e.g., during
angiographic vasospasm. Furthermore, APc was measured
in the aorta and not in the MCA, which might cause a
distortion of the pressure waveform.
The small number of patients with different cerebral
pathologies in this study limits statistical analysis for some
parameters. Moreover, the two groups were treated with
two treatment options (elevated ventilation and osmother-
apy) with very different physiological dynamics. The time
point measures between the groups were not identical and
with the fairly short observation period neither delayed
ICP-rebound effects (as known for osmotherapy) nor neg-
ative CBF changes can be precluded after end of
surveillance. The aim of our study is not to comment upon
the superiority of one treatment over the other. The elab-
orate assessment was used to obtain simultaneous values of
global CBF and the perfusion pressures CPPconv and CPPeff
during treatment-derived changes in cerebral circulation.
Conclusion
Both the TCID technique for assessment of global CBF as
well as the method of effective CPP proved to be applicable
in a neurocritical care setting. Global CBF significantly
decreased under elevated ventilation and temporarily
increased under osmotherapy. During elevated ventilation,
CPPeff was superior when compared to conventially
obtained CPP in reflecting global CBF changes, while after
osmotherapy this correlation was not observed.
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